This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Roche subsidiaries accuse Stanford oncologists, Foresight Diagnostics, of stealing idea behind cancer assay

( July 9, 2024, 10:10 GMT | Official Statement) -- MLex Summary: A lawsuit by Roche Molecular Systems and Roche Sequencing Solutions accuses Stanford oncologists Maximilian Diehn and Arash Ash Alizadeh of breaching the terms of their confidentiality and conflict of interest agreements when developing the “PhasED-Seq” cancer assay for their company, Foresight Diagnostics. “Foresight has raised over $70 million touting technology that improperly uses and relies on Roche Trade Secrets,” the plaintiffs allege. See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections